Evidence map›Paper›PMID 36198676›Full record

ArticleScientific reports2022

Molecular dynamics simulation on surface modification of quantum scaled CuO nano-clusters to support their experimental studies.

Adil Loya, Jacqueline L Stair, Farid Uddin, Guogang Ren

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Salicylic Acid-Modified Sm-TiOThe journal of physical chemistry. C, Nanomaterials and interfaces · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adil LoyaDepartment of Mechanical Engineering, National University of Sciences and Technology, H-12, Islamabad, Pakistan. adil.loya@pnec.nust.edu.pk.
Jacqueline L StairSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB, UK.
Farid UddinSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB, UK.
Guogang RenCollege Lane, School of Engineering and Technology, University of Hertfordshire, Hatfield, AL10 9AB, UK. g.g.ren@herts.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest in nanoparticle modification using functional chemicals has increased rapidly, as it allows more freedom of physiochemical tuning of the nanoparticle's surface into biomedically oriented and designated properties. However, the observation and detection of the thin molecular layers on the nanoparticle surface are very challenging under current analytical facilities. The focus of this research is to demonstrate fundamental interactions between the surface treated nanoparticles and their host liquid media using lab-based experimentation and simulation. In this research, investigation has been carried out on analyzing the surface compatibility and the diffusivity of modified CuO nanoparticles (CuONPs) with short-chain carboxylate-terminated molecules in biofluids. Moreover, during the current Covid-19 pandemic, the Cu/CuONPs have proved effective in killing SARS-CoV1/2 and other airborne viruses. This research was conducted at the molecular level with joint consideration of experimental and simulation studies for characterization of variables. Experimental tests conducted using Fourier Transform Infrared (FTIR) spectroscopy demonstrated several spectral ranges of interest, specifically, detection of three major carboxylate attachments (i.e., 1667-1609 cm

Indexed as

COVID-19Molecular Dynamics SimulationCopperHumansPandemicsSpectroscopy, Fourier Transform InfraredCoppercupric oxide

Identifiers

PMID36198676
PMCPMC9533992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.